arrow
K

Kadoaki Ohashi

Okayama University Hospital
H指数:30
被引数:7,942

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Plain language summary of the J-TAIL-2 study results: a study of Japanese patients with extensive-stage small cell lung cancer that followed their treatment with atezolizumab plus chemotherapy over time

J-TAIL-2研究结果的简明摘要:一项关于日本广泛期小细胞肺癌患者接受阿替利珠单抗联合化疗长期随访的研究

2026-10-010
OA
Molecular Characteristics and Clinical Outcomes of ERBB2-Activating Mutation-Positive Non-Small Cell Lung Cancer: A Japanese Nationwide Real-World Cohort

ERBB2激活突变阳性非小细胞肺癌的分子特征和临床结局:一项日本全国性真实世界队列研究

2026-09-290
OA
Tarlatamab in small cell lung cancer following platinum-based chemotherapy: subgroup analysis of Japanese patients from the DeLLphi-304 study

塔拉他马布在铂类化疗后的小细胞肺癌中的应用:DeLLphi-304研究中日本患者的亚组分析

2026-09-190
OAAI
ULK1, a novel therapeutic target to delay drug tolerance to EGFR-TKIs in an EGFR-mutant non-small cell lung cancer model

ULK1作为EGFR突变非小细胞肺癌模型中延迟EGFR-TKIs药物耐受的新型治疗靶点

2026-07-010
PRE
Limited Immune-Mediated Efficacy of Anti-PD-L1/VEGF in EGFR-TKI-Naïve Egfr-Mutant Lung Cancer with Non-Inflamed Tumor Microenvironment

在非炎症性肿瘤微环境中,EGFR-TKI初治的EGFR突变型肺癌中抗PD-L1/VEGF的有限免疫介导疗效

2026-05-280
OAAI
Stimulator of interferon genes agonist augmented antitumor immunity of osimertinib in Egfr-mutated lung cancer

干扰素基因刺激物激动剂增强了奥希替尼在EGFR突变型肺癌中的抗肿瘤免疫作用

2026-05-210
OAAI
Plasma Protein Analysis for Biomarker Discovery in Lung Cancer Treated With Atezolizumab Combination Therapy in J-TAIL-2

J-TAIL-2研究中接受阿替利珠单抗联合疗法治疗的肺癌患者血浆蛋白质组学分析用于生物标志物发现

2026-04-010
OAAI
Clinical Characteristics and Spatial Transcriptome Analysis of Non-Small Cell Lung Cancers Exhibiting Early Alectinib Resistance: A Retrospective OLCSG Study

非小细胞肺癌早期阿来替尼耐药的临床特征及空间转录组学分析:一项回顾性OLCSG研究

2026-02-011
PRE
Atezolizumab plus Chemotherapy for Advanced Non-Small Cell Lung Cancer in Japanese Clinical Practice (J-TAIL-2)

阿特珠单抗联合化疗治疗日本临床实践中晚期非小细胞肺癌(J-TAIL-2)

2025-12-010
OAAI
Endotracheal and Endobronchial Metastases in Epidermal Growth Factor Receptor Exon 19 Deletion Lung Adenocarcinoma: A Case Successfully Managed with Bronchoscopic Therapy and Sequential Epidermal Growth Factor Receptor Tyrosine Kinase Inhibitors
2025-10-010
PRE
Intracranial activity of sotorasib vs docetaxel in pretreated KRAS G12C-mutated advanced non-small cell lung cancer from a global, phase 3, randomized controlled trial

索托拉西布与多西他赛在经治KRAS G12C突变型晚期非小细胞肺癌中的颅内活性比较:一项全球性、III期、随机对照试验

2025-07-290
OAAI
J-TAIL-2: A Prospective, Observational Study of Atezolizumab Combined With Carboplatin and Etoposide in Patients With Extensive-Stage SCLC in Japan
2025-03-010
OA
Plasma S100A8/A9 level predicts response to immune checkpoint inhibitors in patients with advanced non-small cell lung cancer

血浆S100A8/A9水平预测晚期非小细胞肺癌患者对免疫检查点抑制剂的反应

2025-01-200
OAAI
Plain language summary: tarlatamab for patients with previously treated small cell lung cancer
2024-11-120
OAAI
Tarlatamab for Patients with Previously Treated Small-Cell Lung Cancer

Tarlatamab用于先前治疗的小细胞肺癌患者

2023-11-3091
PRE